2021
DOI: 10.47723/kcmj.v17i2.266
|View full text |Cite
|
Sign up to set email alerts
|

Odontogenic Keratocyst

Abstract: Purpose: to review in detail various aspects of odontogenic keratocyst, emphasizing recent nomenclature, clinical, histopathological, recurrence, and management of odontogenic keratocyst. Methods: To achieve the objective of this review, a manual search was done in hard copy books of oral and maxillofacial pathology, and an electronic search was done in the google website, oral and maxillofacial pathology E-books, virtual database sites, such as PubMed, Research Gate, Academia, and Google scholar using t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 27 publications
(36 reference statements)
0
0
0
Order By: Relevance
“…The non-surgical treatment of OKC has drawn the attention of certain researchers recently. A hedgehog pathway inhibitor (vismodegib) is used orally (150 mg/day for 18 months) to cause cystic shrinking as a more targeted form of treatment for individuals with numerous, recurring, or expansive OKC [ 12 ].…”
Section: Discussionmentioning
confidence: 99%
“…The non-surgical treatment of OKC has drawn the attention of certain researchers recently. A hedgehog pathway inhibitor (vismodegib) is used orally (150 mg/day for 18 months) to cause cystic shrinking as a more targeted form of treatment for individuals with numerous, recurring, or expansive OKC [ 12 ].…”
Section: Discussionmentioning
confidence: 99%